Next chapter for Biden's Cancer Moonshot; postpartum depression's toll on immigrant farmworkers

President Biden's latest Cancer Moonshot efforts are inspiring hope among cancer researchers, but not everyone is impressed.

September 20, 2023 Check out STAT+

Sponsored By

Mike Reddy for STAT STAT+ | AI is coming to your dentist's office. Will it build trust, or erode it? FDA-approved AI dental tools from Pearl, Videa and Overjet gaining use. Dentistry poised to be the fastest adopter of AI tech in health care. By Casey Ross Free Covid tests will be offered again to all U.S. households The Biden administration is offering Covid tests to meet current needs, and to stimulate a testing industry that has faced cratering demand. By Helen Branswell and Rachel Cohrs A needle-free anaphylaxis treatment runs into an FDA roadblock A nasal epinephrine spray called neffy, if approved, would present an alternative to EpiPens for people at risk of severe allergic reactions. By Isabella Cueto Courtesy Matt Miller/Washington University Does the risk of getting long Covid increase each time you get reinfected? Do odds of getting long Covid go up with more coronavirus infections? It's "clear in our data that reinfection contributes additional risk." By Elizabeth Cooney STAT+ | The Apellis eye drug rebound accelerates. This time, it's a competitor falling behind In market battle of drugs for a common type of vision loss, Syfovre by Apellis gains upper hand as questions linger on Astellas' Izervay. By Adam Feuerstein STAT+ | Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro The move comes as more Americans clamor for medicines to lose weight, causing shortages and boosting sales of compounded versions. By Ed Silverman Adobe Researchers use AI to measure recovery from treatment-resistant depression Using brain scans, researchers measured recovery from treatment-resistant depression — a crucial step toward objectively tracking recovery. By Mohana Ravindranath

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser